Multiple Sclerosis ImmunologyThe availability of powerful genome wide association study technology, during the last five years, has shown that most of the new MS susceptibility loci are immune response genes. It is clear that there is much novelty in the field of MS immunology, which has served as an impetus to invest in new therapies. Notably, most if not all of these are immunotherapies. Even the equally exciting field of cell based therapies and neuro regeneration may well